4E-BP1 participates in maintaining spindle integrity and genomic stability via interacting with PLK1

Cell Cycle

Volumn 11, Issue 18, 2012, Pages 3463-3471

  Shang, Zeng Fu ^a   Yu, Lan ^b   Li, Bing ^a   Tu, Wen Zhi ^a,c   Wang, Yu ^a   Liu, Xiao Dan ^a   Guan, Hua ^a   Huang, Bo ^c   Rang, Wei Qing ^c   Zhou, Ping Kun ^a,c  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

4E BP1; Cell cycle; Centrosome; Genomic stability; PLK1; Spindle

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; PACLITAXEL; POLO LIKE KINASE 1; SMALL INTERFERING RNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL SURVIVAL; CENTROSOME; CHROMOSOME; CONTROLLED STUDY; GENOMIC INSTABILITY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROTUBULE; MITOSIS; MOLECULAR DYNAMICS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SPINDLE CELL; TRANSLATION REGULATION; TUMOR CELL;

EID: 84866747992     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21770     Document Type: Article

References (39)

1. Jackson RJ, Wickens M. Translational controls impinging on the 5′-untranslated region and initiation factor proteins. Curr Opin Genet Dev 1997; 7:233-41; PMID:9115426; http://dx.doi.org/10.1016/S0959-437X(97)80133-5.
2. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999; 68:913-63; PMID:10872469; http://dx.doi.org/10.1146/annurev.biochem.68.1. 913.
3. Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009; 10:307-18; PMID:19339977; http://dx.doi.org/10.1038/nrm2672.
4. Herbert TP, Tee AR, Proud CG. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J Biol Chem 2002; 277:11591-6; PMID:11799119; http://dx.doi.org/10.1074/jbc.M110367200.
5. Sivan G, Elroy-Stein O. Regulation of mRNA Translation during cellular division. Cell Cycle 2008; 7:741-4; PMID:18239464; http://dx.doi.org/10.4161/cc. 7.6.5596.
6. Wilker EW, van Vugt MA, Artim SA, Huang PH, Petersen CP, Reinhardt HC, et al. 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 2007; 446:329-32; PMID:17361185; http://dx.doi.org/10.1038/nature05584.
7. Svitkin YV, Herdy B, Costa-Mattioli M, Gingras AC, Raught B, Sonenberg N. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol Cell Biol 2005; 25:10556-65; PMID:16287867; http://dx.doi.org/10.1128/MCB. 25.23.10556-10565.2005.
8. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, et al. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell 2007; 28:501-12; PMID:17996713; http://dx.doi.org/10. 1016/j.molcel.2007.10.019.
9. Ramírez-Valle F, Badura ML, Braunstein S, Narasimhan M, Schneider RJ. Mitotic raptor promotes mTORC1 activity, G(2)/M cell cycle progression, and internal ribosome entry site-mediated mRNA translation. Mol Cell Biol 2010; 30:3151-64; PMID:20439490; http://dx.doi.org/10.1128/MCB.00322-09.
10. Heesom KJ, Gampel A, Mellor H, Denton RM. Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1). Curr Biol 2001; 11:1374-9; PMID:11553333; http://dx.doi.org/10.1016/ S0960-9822(01)00422-5.
11. Greenberg VL, Zimmer SG. Paclitaxel induces the phosphorylation of the eukaryotic translation initiation factor 4E-binding protein 1 through a Cdk1-dependent mechanism. Oncogene 2005; 24:4851-60; PMID:15897904; http://dx.doi.org/10.1038/sj.onc.1208624.
12. Petronczki M, Lénárt P, Peters JM. Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1. Dev Cell 2008; 14:646-59; PMID:18477449; http://dx.doi.org/10.1016/j.devcel.2008.04.014.
13. Barr FA, Silljé HH, Nigg EA. Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 2004; 5:429-40; PMID:15173822; http://dx.doi.org/10.1038/nrm1401.
14. McKenzie L, King S, Marcar L, Nicol S, Dias SS, Schumm K, et al. p53-dependent repression of polo-like kinase-1 (PLK1). Cell Cycle 2010; 9:4200-12; PMID:20962589; http://dx.doi.org/10.4161/cc.9.20.13532.
15. Shah OJ, Anthony JC, Kimball SR, Jefferson LS. 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. Am J Physiol Endocrinol Metab 2000; 279:E715-29; PMID:11001751.
16. Renner AG, Créancier L, Dos Santos C, Fialin C, Recher C, Bailly C, et al. A functional link between polo-like kinase 1 and the mammalian target-of-rapamycin pathway? Cell Cycle 2010; 9:1690-6; PMID:20404504; http://dx.doi.org/10.4161/cc.9.9.11295.
17. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 2004; 5:553-63; PMID:15193258; http://dx.doi.org/10.1016/j.ccr.2004.05. 024.
18. Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, Macoska JA, et al. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 2004; 64:40-7; PMID:14729606; http://dx.doi.org/10.1158/ 0008-5472.CAN-03-1022.
19. Rojo F, Najera L, Lirola J, Jiménez J, Guzmán M, Sabadell MD, et al. 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res 2007; 13:81-9; PMID:17200342; http://dx.doi.org/10.1158/1078-0432.CCR-06-1560.
20. Armengol G, Rojo F, Castellví J, Iglesias C, Cuatrecasas M, Pons B, et al. 4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications. Cancer Res 2007; 67:7551-5; PMID:17699757; http://dx.doi.org/10.1158/0008-5472.CAN-07-0881.
21. Kremer CL, Klein RR, Mendelson J, Browne W, Samadzedeh LK, Vanpatten K, et al. Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate 2006; 66:1203-12; PMID:16652388; http://dx.doi.org/10. 1002/pros.20410.
22. Choo AY, Blenis J. Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 2009; 8:567-72; PMID:19197153; http://dx.doi.org/10.4161/cc.8.4.7659.
23. Zhang Y, Zheng XF. mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors. Cell Cycle 2012; 11:594-603; PMID:22262166; http://dx.doi.org/10.4161/cc.11.3.19096.
24. Azar R, Susini C, Bousquet C, Pyronnet S. Control of contact-inhibition by 4E-BP1 upregulation. Cell Cycle 2010; 9:1241-5; PMID:20372058; http://dx.doi.org/10.4161/cc.9.7.11047.
25. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17:157-62; PMID:17324569; http://dx.doi.org/10.1016/j. gde.2007.02.011.
26. Barnhart BC, Lam JC, Young RM, Houghton PJ, Keith B, Simon MC. Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival. Cancer Biol Ther 2008; 7:1441-9; PMID:18708753; http://dx.doi.org/10.4161/cbt.7.9.6426.
27. Yuan K, Huang Y, Yao X. Illumination of mitotic orchestra during cell division: a Polo view. Cell Signal 2011; 23:1-5; PMID:20633640; http://dx.doi.org/10.1016/j.cellsig.2010.07.003.
28. Zhang SM, Song M, Yang TY, Fan R, Liu XD, Zhou PK. HIV-1 Tat impairs cell cycle control by targeting the Tip60, Plk1 and cyclin B1 ternary complex. Cell Cycle 2012; 11:1217-34; PMID:22391203; http://dx.doi.org/10.4161/cc.11.6.19664.
29. Beugnet A, Wang X, Proud CG. Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1. J Biol Chem 2003; 278:40717-22; PMID:12912989; http://dx.doi.org/10.1074/jbc.M308573200.
30. Constantinou C, Elia A, Clemens MJ. Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1). Biol Cell 2008; 100:279-89; PMID:18021075; http://dx.doi.org/10.1042/BC20070121.
31. Martineau Y, Azar R, Bousquet C, Pyronnet S. Antioncogenic potential of the eIF4E-binding proteins. Oncogene 2012; In Press; PMID:22508483; http://dx.doi.org/10.1038/onc.2012.116.
32. Mundt KE, Golsteyn RM, Lane HA, Nigg EA. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 1997; 239:377-85; PMID:9344838; http://dx.doi.org/10.1006/bbrc.1997.7378.
33. Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, et al.; GEICAM 9906 Study Investigators. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer. J Natl Cancer Inst 2008; 100:805-14; PMID:18505968; http://dx.doi.org/10.1093/jnci/djn151.
34. Ahmed AA, Lu Z, Jennings NB, Etemadmoghadam D, Capalbo L, Jacamo RO, et al.; Australian Ovarian Cancer Study Group. SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer. Cancer Cell 2010; 18:109-21; PMID:20708153; http://dx.doi.org/10.1016/j.ccr.2010.06.018.
35. Spänkuch B, Heim S, Kurunci-Csacsko E, Lindenau C, Yuan J, Kaufmann M, et al. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo. Cancer Res 2006; 66:5836-46; PMID:16740723; http://dx.doi.org/10.1158/0008-5472.CAN-06-0343.
36. Balakumaran BS, Porrello A, Hsu DS, Glover W, Foye A, Leung JY, et al. MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy. Cancer Res 2009; 69:7803-10; PMID:19773438; http://dx.doi.org/10. 1158/0008-5472.CAN-09-0910.
37. rd, Horwitz SB, McDaid HM. Resistance to discoder-molide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent. Proc Natl Acad Sci USA 2011; 108:391-6; PMID:21173253; http://dx.doi.org/10.1073/pnas.1016962108.
38. Shang ZF, Huang B, Xu QZ, Zhang SM, Fan R, Liu XD, et al. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage. Cancer Res 2010; 70:3657-66; PMID:20406977; http://dx.doi.org/10. 1158/0008-5472.CAN-09-3362.
39. Huang S, Shu L, Dilling MB, Easton J, Harwood FC, Ichijo H, et al. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 2003; 11:1491-501; PMID:12820963; http://dx.doi.org/10.1016/S1097-2765(03)00180-1.